<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120229//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.2.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art520.dtd?><?SourceDTD.Version 5.2.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 2?><?origin publisher?><?FILEmeta_MPMED1248 xml ?><?FILEmain xml ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Abingdon)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Abingdon)</journal-id><journal-title-group><journal-title>Medicine (Abingdon, England : UK Ed.)</journal-title></journal-title-group><issn pub-type="ppub">1357-3039</issn><publisher><publisher-name>Medicine Publishing Company Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3929004</article-id><article-id pub-id-type="publisher-id">S1357-3039(13)00301-0</article-id><article-id pub-id-type="doi">10.1016/j.mpmed.2013.10.014</article-id><article-categories><subj-group subj-group-type="heading"><subject>Viral Infections</subject></subj-group></article-categories><title-group><article-title>Emerging infectious diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>van Doorn</surname><given-names>H. Rogier</given-names></name></contrib></contrib-group><aff id="aff1"><bold>H Rogier van Doorn MSc (Med) MSc (Med Biol) MD PhD</bold> is a Clinical Microbiologist from Amsterdam, The Netherlands, who works as a Researcher and Group Head of Emerging Viral Infections at the Oxford University Clinical Research Unit in Ho Chi Minh City, Viet Nam. Conflicts of interest:&#x000a0;none declared</aff><pub-date pub-type="pmc-release"><day>1</day><month>1</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was
					based on <pub-date pub-type="ppub">.--><pub-date pub-type="ppub"><month>1</month><year>2014</year></pub-date><volume>42</volume><issue>1</issue><fpage>60</fpage><lpage>63</lpage><permissions><copyright-statement>&#x000a9; 2014 Elsevier Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Elsevier Ltd</copyright-holder><license><license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p></license></permissions><abstract><p>The spectrum of human pathogens and the infectious diseases they cause is continuously changing through evolution and changes in the way human populations interact with their environment and each other. New human pathogens most often emerge from an animal reservoir, emphasizing the central role that non-human reservoirs play in human infectious diseases. Pathogens may also re-emerge with new characteristics, such as multidrug-resistance, or in different places, such as West Nile virus in the USA in 1999, to cause new epidemics. Most human pathogens have a history of evolution in which they first emerge and cause epidemics, become unstably adapted, re-emerge periodically, and eventually become endemic with the potential for future outbreaks.</p></abstract><kwd-group><title>Keywords</title><kwd>drivers of emergence</kwd><kwd>emerging infections</kwd><kwd>hotspots for emergence</kwd><kwd>species jump</kwd><kwd>zoonosis</kwd></kwd-group></article-meta></front><body><p><boxed-text id="dtbox1"><caption><title>What's new?</title></caption><p><list list-type="simple"><list-item id="u0010"><label>&#x02022;</label><p>Infectious disease are continuously emerging</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>Most known human pathogens are zoonoses</p></list-item><list-item id="u0020"><label>&#x02022;</label><p>Most that are not zoonoses have zoonotic origins</p></list-item><list-item id="u0025"><label>&#x02022;</label><p>Globalization and human invasiveness creates more opportunities for emergence</p></list-item><list-item id="u0030"><label>&#x02022;</label><p>Global surveillance and research consortia and novel technologies will allow for more frequent and more rapid detection of novel pathogens</p></list-item></list></p></boxed-text></p><sec id="sec1"><title>Introduction</title><p>In the 1970s, with antibiotics and vaccines at hand and the eradication of smallpox within reach, there was a general optimism that infectious diseases would soon be a thing of the past. &#x02018;If [&#x02026;] we retain a basic optimism and assume no major catastrophes occur [&#x02026;] the most likely forecast about the future of infectious disease is that it will be very dull&#x02019;.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> The pandemic of HIV crushed this optimism and infectious diseases were put back on the global health agenda of which the 1992 publication &#x02018;Emerging Infections: Microbial Threats to Health in the United States&#x02019;<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> is a landmark. Since then, the ongoing antimicrobial resistance development among many different pathogens, the continuous emergence of (mostly) viruses with potential for human-to-human or pandemic spread, the intentional release of pathogens as terrorist weapons and the heated debates about experiments to make avian influenza viruses transmissible in ferrets are continuously reminding us that infectious diseases are far from dull.</p></sec><sec id="sec2"><title>Definitions</title><p>&#x02018;Emerging infectious diseases&#x02019; are defined as &#x02018;those whose incidence in humans has increased within the past two decades or threatens to increase in the near future. Emergence may be due to the spread of a new agent, to the recognition of an infection that has been present in the population but has gone undetected, or to the realization that an established disease has an infectious origin. Emergence may also be used to describe the reappearance (or re-emergence) of a known infection after a decline in incidence&#x02019;.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref></p></sec><sec id="sec3"><title>Zoonotic emergence</title><p><bold>Pathogen:</bold> there are 1400 known human pathogens, the majority (60%) of which are transmitted to humans zoonotically and depend on an animal reservoir for their survival. An additional smaller proportion (5&#x02013;10%) is environmentally transmitted, and the remainder consists of pathogens that can be maintained by an exclusively human-to-human transmission cycle. Among emerging infections, the proportion of zoonotic infections is even higher (73%), indicating that the human&#x02013;animal interface presents a risk for emergence.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> In addition, almost all (now) established strictly human pathogens have zoonotic origins:<xref rid="bib3 bib4" ref-type="bibr"><sup>3,4</sup></xref> these pathogens have moved from animals into humans and fully adapted to them during many millennia of human and pathogen evolution.</p><p><bold>Human:</bold> because most human pathogens rely on an animal or environmental reservoir, the interactions between human populations and their surrounding ecosystem determine the local pathogen spectrum, and the interpopulation interactions determine the spread of these pathogens. Historically, there have been several profound and distinct transitions in human environmental and interpopulation interactions that have radically changed the spectrum and causes of infectious disease in human populations (<xref rid="tbl1" ref-type="table">Table 1</xref>). Today, we are living through the fourth great historical transition. The invasiveness of human activity into all geographic areas of the world, the globalization of economic activities and culture, the speed and accessibility of distant contact, the spread and intensification of urbanization, and our increasing reliance on either intricate or massive technology, are reshaping the relations between humans and microbes.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref></p><p><bold>The species jump:</bold> the species jump that initiates a first human infection by a new agent is often brought about by a novel or unusual physical contact between potential pathogen and human. Such contacts usually occur because of cultural, social, behavioural or technological change on the part of humans that affects the human&#x02013;animal interface. The potential for subsequent spread of this &#x02018;new&#x02019; infectious disease will depend on many different factors, including environmental or social factors. These changes and factors are the drivers of emergence and are listed in <xref rid="tbl2" ref-type="table">Table 2</xref>.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref></p><p>Biologically, the species jump is often more a transition process involving several stages rather than a single event. These stages are displayed in <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> The pathogen has to overcome various biological barriers (interspecies, intrahuman and interhuman) to move from one stage to the next, to be able finally to cause sustained human-to-human transmission.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> Based on data from 1940 onwards, the hotspots for emergence of infectious diseases were mapped for zoonotic infections from wildlife and domestic animals, and for drug-resistant and vector-borne organisms. <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref> shows that these hotspots are primarily located in South and South East Asia, South and Central America and Subsaharan Africa.<xref rid="bib8 bib9" ref-type="bibr"><sup>8,9</sup></xref></p><p>Various international consortia and large research programmes have been established in an attempt to predict and prevent, or prepare for and mitigate, these novel emergence events, summarized in a recent issue of <italic>The Lancet</italic>.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> Technical advances enable us to detect and characterize these agents much more rapidly than ever before (e.g. availability of whole genome sequences of influenza virus A/H7N9 influenza or <italic>Escherichia coli</italic> O104:H4 within days).<xref rid="bib10 bib11" ref-type="bibr"><sup>10,11</sup></xref></p></sec><sec id="sec4"><title>Non-zoonotic emergence</title><p>The emergence of novel zoonotic pathogens is appealing to the imagination and draws plenty of popular and scientific media attention, but does not necessarily represent the largest threat from infectious diseases. There is a rapid and increasing spread of antimicrobial drug resistance among bacteria and other pathogens, and the development of novel antimicrobial agents has almost come to a stop because drug companies do not consider them profitable: a combination that may set us back to the pre-antibiotic era. Drug resistance is a threat not only to the successful treatment of HIV, malaria and tuberculosis, but also, increasingly, of hospital- and community-acquired infections from &#x02018;normal&#x02019; Gram-positive and Gram-negative bacteria. Failure of vaccination programmes because of bad press or religious conviction in developed countries can cause re-emergence of highly infectious viruses, such as those that cause measles or rubella, within years, as has happened in the UK and the Netherlands. Global food production and distribution processes may give rise to widely disseminated foodborne infections that are hard to tackle, as with <italic>E. coli</italic> O104:H4 in and out of Germany, recently. Finally, in South East Asia, while H5N1 and H7N9 influenza viruses attract most international attention, hand, foot and mouth disease, caused by the exclusively human pathogen, enterovirus 71, is now associated annually with hundreds of thousands of hospitalizations of children under 5, with a mortality of around 0.1%,<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> showing that humans can also be a source of emerging infections (<xref rid="tbl3" ref-type="table">Table 3</xref>).</p></sec><sec sec-type="conclusions" id="sec5"><title>Conclusion</title><p>For daily medical practice it is important for doctors, and especially infectious disease physicians, to be aware of events of emergence and countries where processes of emergence and species-jumping are occurring (e.g. by subscribing to ProMED, WHO influenza update or others). It is crucial that for each patient the history should include a travel history, which involves more than asking merely for the name of the country that a patient has visited. In the end, despite sophisticated surveillance programmes, it is usually an astute clinician who, after having seen or heard one or two extraordinary patient histories, makes&#x000a0;the connection and sees the first signs of an event of emergence.</p></sec></body><back><ref-list><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="book" id="sref1"><person-group person-group-type="author"><name><surname>Burnet</surname><given-names>F.M.</given-names></name><name><surname>White</surname><given-names>D.O.</given-names></name></person-group><chapter-title>Natural history of infectious disease</chapter-title><edition>4th edn</edition><year>1972</year><publisher-name>University Press</publisher-name><publisher-loc>Cambridge [Eng.]</publisher-loc></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="book" id="sref2"><person-group person-group-type="author"><name><surname>Lederberg</surname><given-names>J.</given-names></name><name><surname>Shope</surname><given-names>R.E.</given-names></name><name><surname>Oaks</surname><given-names>S.C.</given-names></name></person-group><chapter-title>Institute of Medicine (U.S.). Committee on emerging microbial threats to health. Emerging infections: microbial threats to health in the United States</chapter-title><year>1992</year><publisher-name>National Academy Press</publisher-name><publisher-loc>Washington, D.C.</publisher-loc></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>L.H.</given-names></name><name><surname>Latham</surname><given-names>S.M.</given-names></name><name><surname>Woolhouse</surname><given-names>M.E.</given-names></name></person-group><article-title>Risk factors for human disease&#x000a0;emergence</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><volume>356</volume><year>2001</year><fpage>983</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">11516376</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>R.A.</given-names></name></person-group><article-title>The Leeuwenhoek Lecture 2001. Animal origins of human&#x000a0;infectious disease</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><volume>356</volume><year>2001</year><fpage>957</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">11405946</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>McMichael</surname><given-names>A.J.</given-names></name></person-group><article-title>Environmental and social influences on emerging infectious diseases: past, present and future</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><volume>359</volume><year>2004</year><fpage>1049</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">15306389</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>N.D.</given-names></name><name><surname>Dunavan</surname><given-names>C.P.</given-names></name><name><surname>Diamond</surname><given-names>J.</given-names></name></person-group><article-title>Origins of major human infectious diseases</article-title><source>Nature</source><volume>447</volume><year>2007</year><fpage>279</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">17507975</pub-id></element-citation></ref><ref id="bib7"><label>7</label><mixed-citation publication-type="other" id="oref1">ANTIGONE (ANTIcipating the Global Onset of Novel Epidemics). [cited; Available from: <ext-link ext-link-type="uri" xlink:href="http://www.antigonefp7.eu/" id="intref0010">http://www.antigonefp7.eu/</ext-link>.</mixed-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Morse</surname><given-names>S.S.</given-names></name><name><surname>Mazet</surname><given-names>J.A.</given-names></name><name><surname>Woolhouse</surname><given-names>M.</given-names></name></person-group><article-title>Prediction and prevention of the next pandemic zoonosis</article-title><source>Lancet</source><volume>380</volume><year>2012</year><fpage>1956</fpage><lpage>1965</lpage><pub-id pub-id-type="pmid">23200504</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>K.E.</given-names></name><name><surname>Patel</surname><given-names>N.G.</given-names></name><name><surname>Levy</surname><given-names>M.A.</given-names></name></person-group><article-title>Global trends in emerging infectious diseases</article-title><source>Nature</source><volume>451</volume><year>2008</year><fpage>990</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">18288193</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>Human infection with a novel avian-origin influenza A (H7N9) virus</article-title><source>N&#x000a0;Engl J Med</source><volume>368</volume><year>2013</year><fpage>1888</fpage><lpage>1897</lpage><pub-id pub-id-type="pmid">23577628</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Rohde</surname><given-names>H.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name></person-group><article-title>Open-source genomic analysis of&#x000a0;Shiga-toxin-producing E. coli O104:H4</article-title><source>N&#x000a0;Engl J Med</source><volume>365</volume><year>2011</year><fpage>718</fpage><lpage>724</lpage><pub-id pub-id-type="pmid">21793736</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Khanh</surname><given-names>T.H.</given-names></name><name><surname>Sabanathan</surname><given-names>S.</given-names></name><name><surname>Thanh</surname><given-names>T.T.</given-names></name></person-group><article-title>Enterovirus 71-associated hand, foot, and mouth disease, Southern Vietnam, 2011</article-title><source>Emerg Infect Dis</source><volume>18</volume><year>2012</year><fpage>2002</fpage><lpage>2005</lpage><pub-id pub-id-type="pmid">23194699</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Adapted from Wolfe ND et&#x000a0;al. Origins of major human infectious diseases. Nature 2007; 447 (7142).</p></caption><graphic xlink:href="gr1"/><attrib>Reprinted by permission from Macmillan Publishers Ltd.</attrib></fig><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Global hotspots for emerging diseases originating in wildlife.</p></caption><graphic xlink:href="gr2"/><attrib>From Morse SS, Mazet JA, Woolhouse M, Parrish CR, Carroll D, Karesh WB et&#x000a0;al. Prediction and prevention of the next pandemic zoonosis. <italic>Lancet</italic>. 2012 Dec 1;<bold>380</bold>:1956&#x02013;65. With permission from Elsevier.</attrib></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Transitions in human environmental and interpopulation interactions through time</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Transition, time</th><th>Major change</th></tr></thead><tbody><tr><td>Prehistoric transition, millions of years ago</td><td>From tree-dwelling to savannah, hunter-gatherer</td></tr><tr><td colspan="2">Historic transitions</td></tr><tr><td><list list-type="simple"><list-item id="u0035"><label>&#x02022;</label><p>first (local), 5000&#x02013;10,000 years ago</p></list-item></list></td><td>Settlements, crop and livestock domestication</td></tr><tr><td><list list-type="simple"><list-item id="u0040"><label>&#x02022;</label><p>second (continental), 1000&#x02013;3000 years ago</p></list-item></list></td><td>Intracontinental military and commercial contacts</td></tr><tr><td><list list-type="simple"><list-item id="u0045"><label>&#x02022;</label><p>third (intercontinental), from AD 1500</p></list-item></list></td><td>European exploration and imperialism</td></tr><tr><td><list list-type="simple"><list-item id="u0050"><label>&#x02022;</label><p>fourth (global), today</p></list-item></list></td><td>Globalization, urbanization, climate change</td></tr></tbody></table></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Biological, social and environmental drivers of emergence of infectious disease</p></caption><table frame="hsides" rules="groups"><tbody><tr><td><list list-type="simple"><list-item id="u0055"><label>&#x02022;</label><p>Microbial adaptation and change</p></list-item><list-item id="u0060"><label>&#x02022;</label><p>Susceptibility to infection</p></list-item><list-item id="u0065"><label>&#x02022;</label><p>Climate, weather and the environment</p></list-item><list-item id="u0070"><label>&#x02022;</label><p>Economic development and land use</p></list-item><list-item id="u0075"><label>&#x02022;</label><p>Human demographics and behaviour</p></list-item><list-item id="u0080"><label>&#x02022;</label><p>Technology and industry</p></list-item><list-item id="u0085"><label>&#x02022;</label><p>International travel and commerce</p></list-item><list-item id="u0090"><label>&#x02022;</label><p>Breakdown in public health</p></list-item><list-item id="u0095"><label>&#x02022;</label><p>Poverty and social inequality</p></list-item><list-item id="u0100"><label>&#x02022;</label><p>War and conflict</p></list-item><list-item id="u0105"><label>&#x02022;</label><p>Urban decay</p></list-item><list-item id="u0110"><label>&#x02022;</label><p>Lack of political will</p></list-item><list-item id="u0115"><label>&#x02022;</label><p>Intentional biological attacks</p></list-item></list></td></tr></tbody></table></table-wrap><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><p>Selection of important emerging infectious diseases from the last decade</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>2013</td><td>Influenza virus A/H7N9</td></tr><tr><td>2012</td><td>Middle East respiratory syndrome (MERS) &#x02013; coronavirus</td></tr><tr><td>2011</td><td><italic>Escherichia coli</italic> 0104:H4</td></tr><tr><td>2010</td><td>Huaiyangshan virus, associated with severe fever and thrombocytopenia syndrome (SFTS)</td></tr><tr><td>2009</td><td>Influenza virus A/H1N1pdm09</td></tr><tr><td rowspan="2">2008</td><td><italic>Plasmodium knowlesi</italic></td></tr><tr><td>Lujo virus</td></tr><tr><td>2005</td><td>Human retroviruses HTLV3 and HTLV4</td></tr><tr><td>2004</td><td>Re-emergence of influenza virus A/H5N1</td></tr><tr><td>2003</td><td>SARS coronavirus</td></tr></tbody></table><attrib>Adapted from <ext-link ext-link-type="uri" xlink:href="http://www.hpa.org.uk/" id="intref0015">www.hpa.org.uk</ext-link></attrib></table-wrap></floats-group></article>